E

CERo Therapeutics Holdings, Inc. CERO

OTC PK
Recommendation
Dividend Power Score
Day's Range
$0.01$0.01
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Corporate Info
Phone Number
650 407 2376
Address
201 Haskins Way
Suite 230
South San Francisco, CA 94080
Country
United States
Year Founded
2021
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
8
Business Description
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.